104 research outputs found
Cardiocladius oliffi (Diptera: Chironomidae) as a potential biological control agent against Simulium squamosum (Diptera: Simuliidae)
<p>Abstract</p> <p>Background</p> <p>The control of onchocerciasis in the African region is currently based mainly on the mass drug administration of ivermectin. Whilst this has been found to limit morbidity, it does not stop transmission. In the absence of a macrofilaricide, there is a need for an integrated approach for disease management, which includes vector control. Vector control using chemical insecticides is expensive to apply, and therefore the use of other measures such as biological control agents is needed. Immature stages of <it>Simulium squamosum</it>, reared in the laboratory from egg masses collected from the field at Boti Falls and Huhunya (River Pawnpawn) in Ghana, were observed to be attacked and fed upon by larvae of the chironomid <it>Cardiocladius oliffi </it>Freeman, 1956 (Diptera: Chironomidae).</p> <p>Methods</p> <p><it>Cardiocladius oliffi </it>was successfully reared in the rearing system developed for <it>S. damnosum </it>s.l. and evaluated for its importance as a biological control agent in the laboratory.</p> <p>Results</p> <p>Even at a ratio of one <it>C. oliffi </it>to five <it>S. squamosum</it>, they caused a significant decrease in the number of adult <it>S. squamosum </it>emerging from the systems (treatments). Predation was confirmed by the amplification of <it>Simulium </it>DNA from <it>C. oliffi </it>observed to have fed on <it>S. squamosum </it>pupae. The study also established that the chironomid flies could successfully complete their development on a fish food diet only.</p> <p>Conclusion</p> <p><it>Cardiocladius oliffi </it>has been demonstrated as potential biological control agent against <it>S. squamosum</it>.</p
Propagating the fear of witchcraft: Pentecostal prophecies in the new prophetic churches in South Africa
Pentecostal prophecy is one of the major themes of the
theology and practice of religion among the prophets of
New Prophetic Churches in South Africa and a major factor
to the growth and expansion of Pentecostalism in Southern
Africa. This paper offers a reflection on the role of prophecy
in relation to the fear of witchcraft in the region. The
contribution is that Pentecostal prophecy is not always in
confrontation but sometime propels the fear of witchcraft.
Through media analysis, the paper illustrates with some
examples of Pentecostal prophecies on witchcraft how
Pentecostal prophecy can aid rather than dispel fear of
witchcraft. These prophecies raise several challenges to the
discernment of Pentecostal prophetic ministry.Christian Spirituality, Church History and Missiolog
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma
Aberrant Hedgehog/GLI signaling has been implicated in a diverse spectrum of human cancers, but its role in lung adenocarcinoma (LAC) is still under debate. We show that the downstream effector of the Hedgehog pathway, GLI1, is expressed in 76% of LACs, but in roughly half of these tumors, the canonical pathway activator, Smoothened, is expressed at low levels, possibly owing to epigenetic silencing. In LAC cells including the cancer stem cell compartment, we show that GLI1 is activated noncanonically by MAPK/ERK signaling. Different mechanisms can trigger the MAPK/ERK/GLI1 cascade including KRAS mutation and stimulation of NRP2 by VEGF produced by the cancer cells themselves in an autocrine loop or by stromal cells as paracrine cross talk. Suppression of GLI1, by silencing or drug-mediated, inhibits LAC cells proliferation, attenuates their stemness and increases their susceptibility to apoptosis in vitro and in vivo. These findings provide insight into the growth of LACs and point to GLI1 as a downstream effector for
oncogenic pathways. Thus, strategies involving direct inhibition of GLI1 may be useful in the treatment of LACs
Merkel Cell Carcinoma with a Suppressor of Fused (SUFU) Mutation: Case Report and Potential Therapeutic Implications
Evaluation of prognostic risk models for postoperative pulmonary complications in adult patients undergoing major abdominal surgery: a systematic review and international external validation cohort study
Background
Stratifying risk of postoperative pulmonary complications after major abdominal surgery allows clinicians to modify risk through targeted interventions and enhanced monitoring. In this study, we aimed to identify and validate prognostic models against a new consensus definition of postoperative pulmonary complications.
Methods
We did a systematic review and international external validation cohort study. The systematic review was done in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We searched MEDLINE and Embase on March 1, 2020, for articles published in English that reported on risk prediction models for postoperative pulmonary complications following abdominal surgery. External validation of existing models was done within a prospective international cohort study of adult patients (≥18 years) undergoing major abdominal surgery. Data were collected between Jan 1, 2019, and April 30, 2019, in the UK, Ireland, and Australia. Discriminative ability and prognostic accuracy summary statistics were compared between models for the 30-day postoperative pulmonary complication rate as defined by the Standardised Endpoints in Perioperative Medicine Core Outcome Measures in Perioperative and Anaesthetic Care (StEP-COMPAC). Model performance was compared using the area under the receiver operating characteristic curve (AUROCC).
Findings
In total, we identified 2903 records from our literature search; of which, 2514 (86·6%) unique records were screened, 121 (4·8%) of 2514 full texts were assessed for eligibility, and 29 unique prognostic models were identified. Nine (31·0%) of 29 models had score development reported only, 19 (65·5%) had undergone internal validation, and only four (13·8%) had been externally validated. Data to validate six eligible models were collected in the international external validation cohort study. Data from 11 591 patients were available, with an overall postoperative pulmonary complication rate of 7·8% (n=903). None of the six models showed good discrimination (defined as AUROCC ≥0·70) for identifying postoperative pulmonary complications, with the Assess Respiratory Risk in Surgical Patients in Catalonia score showing the best discrimination (AUROCC 0·700 [95% CI 0·683–0·717]).
Interpretation
In the pre-COVID-19 pandemic data, variability in the risk of pulmonary complications (StEP-COMPAC definition) following major abdominal surgery was poorly described by existing prognostication tools. To improve surgical safety during the COVID-19 pandemic recovery and beyond, novel risk stratification tools are required.
Funding
British Journal of Surgery Society
0185 High-dose fulvestrant (500 mg): Clinical evidence supporting potentially improved efficacy benefits in hormone receptor-positive (HR+) advanced breast cancer (ABC)
Ascorbic acid supplementation improved antibody response to infectious bursal disease vaccination in chickens
- …
